• 1. Alumina coating on 5 V lithium cobalt fluorophosphate cathode material for lithium secondary batteries – synthesis and electrochemical properties?
  S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115
• 2. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 3. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 4. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis
• 5. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Carboxylic acid derivatives Carboxylic acid amides

Comprehensive Overview of 1H-Imidazole-4-carboxamide, 5-amino-1-methyl- (CAS No. 21343-04-4)

1H-Imidazole-4-carboxamide, 5-amino-1-methyl- (CAS No. 21343-04-4) is a versatile compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as 5-Amino-1-methylimidazole-4-carboxamide, has garnered attention due to its potential therapeutic properties and its role in various biological processes. This comprehensive overview aims to provide a detailed understanding of the chemical structure, synthesis methods, biological activities, and recent research advancements related to this compound.

The chemical structure of 1H-Imidazole-4-carboxamide, 5-amino-1-methyl- is characterized by an imidazole ring with a carboxamide group at the 4-position and an amino group at the 5-position. The presence of a methyl group at the 1-position further enhances its structural complexity and reactivity. The imidazole ring is a common moiety found in many biologically active molecules, including histidine residues in proteins and purine bases in nucleic acids. This structural similarity contributes to the compound's ability to interact with various biological targets.

The synthesis of 1H-Imidazole-4-carboxamide, 5-amino-1-methyl- has been extensively studied, with several methods reported in the literature. One common approach involves the reaction of 5-aminoimidazole with methylamine and a carboxylic acid derivative, such as acyl chloride or acid anhydride. Another method involves the condensation of 5-aminoimidazole with methylamine followed by carboxylation. These synthetic routes provide researchers with flexible options to produce the compound in high purity and yield.

In terms of biological activities, 1H-Imidazole-4-carboxamide, 5-amino-1-methyl- has shown promising results in various preclinical studies. Research has indicated that this compound exhibits anti-inflammatory properties by modulating the activity of specific enzymes involved in inflammatory pathways. Additionally, it has been investigated for its potential as an antiviral agent, particularly against certain RNA viruses. The mechanism of action is believed to involve interference with viral replication processes.

Recent studies have also explored the potential of 1H-Imidazole-4-carboxamide, 5-amino-1-methyl- in cancer therapy. Preliminary findings suggest that it may have antiproliferative effects on certain cancer cell lines by inducing apoptosis and inhibiting cell cycle progression. These effects are attributed to its ability to interact with key signaling pathways involved in cell survival and proliferation.

The pharmacokinetic properties of 1H-Imidazole-4-carboxamide, 5-amino-1-methyl- have been evaluated in animal models to assess its suitability for therapeutic applications. Studies have shown that it exhibits good oral bioavailability and a favorable pharmacokinetic profile, making it a promising candidate for further development as a drug molecule.

To enhance its therapeutic potential, researchers are actively investigating structure-activity relationships (SAR) to identify analogs with improved potency and selectivity. Computational methods, such as molecular docking and molecular dynamics simulations, are being employed to predict the binding modes and interactions of these analogs with their target proteins.

In conclusion, 1H-Imidazole-4-carboxamide, 5-amino-1-methyl- (CAS No. 21343-04-4) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure and diverse biological activities make it an attractive target for further investigation and development. Ongoing research efforts are expected to uncover new applications and optimize its therapeutic properties for various medical conditions.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)